PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF)- Russian Payer Perspective

Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.662
https://www.valueinhealthjournal.com/article/S1098-3015(12)00727-9/fulltext
Section Title : Cardiovascular Disorders
Section Order : 137
First Page : A122
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00727-9&doi=10.1016/j.jval.2012.03.662
HEOR Topics :
Tags :
Regions :